Dual-listed healthcare product company Ebos has guided for yet another year of strong earnings growth dispute the loss of its lucrative supply agreement with the Chemist Warehouse Australia.
The contract finished at the end of its 2024 financial year on June 30 and Ebos has indicated that the group
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
